VistaGen Therapeutics CEO Shawn Singh joins Jill Malandrino on Nasdaq #TradeTalks to discuss a drug that has the potential to become the first FDA-approved on-demand treatment for social anxiety.#nasdaq #stockmarket #stocks #finance #financial #trading #trader #stock